Showing results (1151-1160 of 1,637) with videos related to
Sort By:
Pageof 164
Campbell Systematic Reviews|June 26, 2023
PROTOCOL: Value chain interventions for improving women's economic empowerment: A mixed-method systematic reviewSuchi Kapoor Malhotra, Ashrita Saran, Sabina Singh, et al.Psychological Medicine|December 16, 2003
Prospective evaluation of neurological soft signs in first-episode schizophrenia in relation to psychopathology: state versus trait phenomenaP Whitty, M Clarke, S Browne, et al.Cells|December 17, 2024
Macrophage Inhibitor Clodronate Enhances Liver Transduction of Lentiviral but Not Adeno-Associated Viral Vectors or mRNA Lipid Nanoparticles in Neonatal and Juvenile MiceLoukia Touramanidou, Sonam Gurung, Claudiu A Cozmescu, et al.Journal of the American Chemical Society|June 1, 2021
An Organometallic Strategy for Cysteine BorylationMary A Waddington, Xin Zheng, Julia M Stauber, et al.Chemical Research in Toxicology|November 10, 2020
Cell Membrane Transporters Facilitate the Accumulation of Hepatocellular Flucloxacillin Protein Adducts: Implication in Flucloxacillin-Induced Liver InjuryJames C Waddington, Serat-E Ali, Sophie L Penman, et al.Muscle & Nerve|December 7, 2017
Estimating the global prevalence of transthyretin familial amyloid polyneuropathyHartmut H Schmidt, Márcia Waddington-Cruz, Marc F Botteman, et al.European Psychiatry : the Journal of the Association of European Psychiatrists|May 26, 2004
Neurological soft signs and dermatoglyphic anomalies in twins with schizophreniaBrendan D Kelly, David Cotter, Cian Denihan, et al.Chemical Research in Toxicology|October 19, 2017
Dapsone and Nitroso Dapsone Activation of Naı̈ve T-Cells from Healthy DonorsAbdulaziz Alzahrani, Monday Ogese, Xiaoli Meng, et al.Complementary Therapies in Clinical Practice|January 22, 2017
Staff perspectives regarding the implementation of a yoga intervention with chronic pain self-management in a clinical settingEmily A Waddington, Reid K Rogers Fuller, Rachel C K Barloon, et al.Human Molecular Genetics|January 11, 2020
Systemic AAV9 gene therapy using the synapsin I promoter rescues a mouse model of neuronopathic Gaucher disease but with limited cross-correction potential to astrocytesGiulia Massaro, Michael P Hughes, Sammie M Whaler, et al.Pageof 164